THER-16. EFFICACY OF UPFRONT IMMUNE CHECKPOINT INHIBITORS IN LUNG CANCER BRAIN METASTASIS

INTRODUCTION: Immune checkpoint inhibitors (ICI) have resulted in improved outcomes in a subset of patients with lung cancer. However, data describing the efficacy of ICI in lung cancer brain metastasis (LCBM) is limited. We analyzed overall survival (OS) in patients with LCBM treated with upfront I...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neurooncol Adv
Auteurs principaux: Barnett, Addison, Lauko, Adam, Ali, Assad, Li, Hong, Sagar, Soumya, Chao, Samuel, Pennell, Nathan, Peereboom, David, Stevens, Glen, Angelov, Lilyana, Yu, Jennifer, Murphy, Erin, Mohammadi, Alireza, Suh, John, Barnett, Gene, Ahluwalia, Manmeet
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213459/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz014.059
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires